Novartis making history in blood cancer for decades
Novartis announced fourth quarter and full year financial results for 2021 on February 02, 2022
Our primary concern at Novartis remains the health and safety of our associates and patients globally, and it is ...
Novartis focuses its business on three leading divisions on a global scale: pharmaceuticals, eye care and generics.
